SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060599
Filing Date
2024-05-15
Accepted
2024-05-15 17:21:31
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20240331.htm   iXBRL 10-Q 927200
2 EX-10.1 hcwb-ex10_1.htm EX-10.1 210012
3 EX-10.5 hcwb-ex10_5.htm EX-10.5 216431
4 EX-31.1 hcwb-ex31_1.htm EX-31.1 14475
5 EX-31.2 hcwb-ex31_2.htm EX-31.2 14353
6 EX-32.1 hcwb-ex32_1.htm EX-32.1 9469
7 EX-32.2 hcwb-ex32_2.htm EX-32.2 9219
  Complete submission text file 0000950170-24-060599.txt   4460975

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240331.xsd EX-101.SCH 795686
53 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240331_htm.xml XML 393737
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 24952644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)